A case treated with Crizotinib after secondary MET amplification of A double Rare L747S and G719S EGFR mutation Pulmonary Sarcomatoid Carcinoma期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

A case treated with Crizotinib after secondary MET amplification of A double Rare L747S and G719S EGFR mutation Pulmonary Sarcomatoid Carcinoma

Institution:	1. Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China;2. Department of Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China;3. Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China;4. Department of Pathology, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China;5. Department of Pathology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China;6. Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！